ANKARA, Jun 23 (NNN-ANADOLU) – Turkish President, Recep Tayyip Erdogan, yesterday announced the phase III trials, of its indigenous COVID-19 vaccine, named Turkovac.
The vaccine, which is made with inactivated coronaviruses, is expected to be available for use by the end of this year, Erdogan said, at an event for the inoculation of the first phase III volunteers with the vaccine.
Turkey yesterday confirmed 6,143 new COVID-19 cases, including 565 symptomatic patients, raising the total number of cases in the country to 5,381,736, according to the health ministry.
The death toll from the virus rose by 57 to 49,293, while the total recoveries climbed to 5,242,945, after 5,214 more people recovered in the last 24 hours.
A total of 223,238 tests were conducted over the past day, with the overall number of tests reaching 58,997,073.
Turkey started mass COVID-19 vaccination on Jan 14, after the authorities approved the emergency use of the Chinese Sinovac vaccine. More than 29,093,000 people have been vaccinated in the country so far.
